NSN 6505-01-675-5542, 6505016755542
TAFENOQUINE TABLETS

Federal Supply Classification: FSC 6505 - Drugs and Biologicals
National Item Identification Number: NIIN 016755542
Codification Country: United States
Item Name Code: INC 77777
Criticality: (X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code: (P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.

Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know

CALL ABOUT NSN 6505-01-675-5542

Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

REQUEST QUOTE for 6505-01-675-5542

Have a list that needs to be quoted? Upload it here.

Upload a List

DLMS^® Summary

National Stock Number 6505-01-675-5542

National Stock Number (NSN) 6505-01-675-5542, or NIIN 016755542, (tafenoquine tablets) was assigned September 17, 2018 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 4 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has been procured by the US Government within the last year, but shows no recent (last 90 days) procurement activity. There have been 7 contracts issued for this part number, with 7 awards given. There is minimal competition for this NSN. The US Government has awarded contracts to 3 different suppliers. The last contract numbers awarded were: SPE2DP25V0588, SPE2DP25V0588, SPE2DP25V0588, SPE2DP25V0497, SPE2DP25V0252. The total value of the awarded contracts has been US$ 5,223.46.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries. Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on May 23, 2019, this NSN's acquisition method was noted as: Suitable for Competitive Acquisition. (Potential sources shall include dealers/distributors.) This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505016755542 does not contain precious metals.

This information was last updated on Jul 01, 2025.

Technical Characteristics

SPECIAL FEATURES: (FEAT) ARAKODA 100 MG, 16 (2 X 8) UNIT DOSE TABLETS. FOR 18 YEARS OF AGE AND OLDER. ARAKODA TABLETS CONTAIN 100MG OF TAFENOQUINE (EQUIVALENT TO 125.5MG OF TAFENOQUINE SUCCINATE); TABLETS ARE DARK PINK, FILM-COATED, CAPSULE-SHAPED, AND DEBOSSED WITH "TQ100" ON ONE SIDE; ARAKODA TABLETS ARE PACKED IN POLYAMIDE ALUMINUM AND PVX FORMABLE LAMINATE BACKED BLISTER PACKS; ESTIMATED SHELF LIFE: 24 MONTHS; STORED AT 20-25 DEGREES CENTIGRADE (68-77 DEGREES F); EACH BLISTER PACK CONTAINS 8 TABLETS; EACH CARTON (PACKET) CONTAINS 16 TABLETS (2 BLISTER PACKS).
III PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) ARAKODA (TAFENOQUINE) TABLETS FOR ORAL USE, 100MG, 16 TABLETS
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) TAFENOQUINE TABLETS FOR ORAL USE, 100MG, 16 TABLETS
SPECIAL FEATURES: (FEAT) TAFENOQUINE 100 MG, 16 (2 X 8) UNIT DOSE TABLETS. CONTAIN 16 TABLETS (2) BLISTER CARDS PER PACKAGE. FOR 18 YEARS OF AGE AND OLDER. STORE AT 20 C TO 25 C (68 F TO 77 F).
PART NAME ASSIGNED BY CONTROLLING AGENCY: (CXCY) ARAKODA (TAFENOQUINE) TABLETS FOR ORAL USE, 100MG, 16 TABLETS